Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 37/100 | DilutionWatch score record |
| Shares Outstanding | 5.78M | Verified float table or market cache |
| Public Float | 3.65M | Verified float table or market cache |
| Market Cap | $43.98M | Market data cache |
| Cash Runway | 56.1 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | $9.50M | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 7.
Recent SEC source mix: 4 2, 424B5 2, 8-K 1, XBRL 2.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
XLO SEC Filing Activity — Last 12 Months
Shares outstanding reported by XLO on the cover page of its latest 10-K/10-Q: 5.78M as of March 18, 2026.
DilutionWatch recorded 1 registration or prospectus document for XLO (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| S-3 | shelf registration | 1 | May 12, 2026 |
| EFFECT | SEC declared a registration effective | 1 | Jun 01, 2026 |
| 8-K | current report (material event) | 7 | Aug 12, 2026 |
| 10-K | annual report | 1 | Mar 23, 2026 |
| 10-Q | quarterly report | 2 | Aug 12, 2026 |
| DEF 14A | proxy statement | 1 | Apr 28, 2026 |
| 3 | initial insider ownership | 8 | Aug 12, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual XLO Dilution Snapshot
Xilio Therapeutics, Inc. (XLO) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: October 27, 2026.
- Stored ATM program remaining capacity: $9.5M.
- Recent SEC activity tracked for XLO: 4 on 2026-03-30; xbrl on 2026-03-23; 4 on 2026-02-17.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
XLO's DilutionScore is currently 37/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 46/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Aug 22 – Oct 27, 2026 | 37/100 | MEDIUM | 67 days |
| Aug 14 – Aug 21, 2026 | 46/100 | MEDIUM | 7 days |
| Jul 30 – Aug 13, 2026 | 36/100 | MEDIUM | 15 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
XLO shares outstanding have decreased 91.9% from 73.46M (Mar 2026) to 5.98M (May 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| May 15, 2026 | 5.98M | 3.65M | ▲ 3.46% |
| May 09, 2026 | 5.98M | 3.52M | ▲ 2.27% |
| Apr 17, 2026 | 5.78M | 3.45M | ▼ 0.15% |
| Mar 28, 2026 | 5.78M | 3.45M | ▲ 19.07% |
| Mar 25, 2026 | 5.25M | 2.90M | ▲ 54.20% |
| Mar 13, 2026 | 73.46M | 26.32M | ▲ 65.09% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.